WORLD Law Direct Forums
Home > WORLD Law Direct Forums > FORUM INFORMATION > Law News > International Law News > Indian Patent office to hear drug firms’ views before granting licence

Indian Patent office to hear drug firms’ views before granting licence

This is a discussion on Indian Patent office to hear drug firms’ views before granting licence within the International Law News forum, part of the Law News category; The Indian patent office will provide drug innovators a chance to explain their views before a decision to grant compulsory ...

Consult Your Own Personal Lawyer Now!
Reply

 

Thread Tools Search this Thread Rate Thread Display Modes
Old Jul 8th, 2008, 06:44 AM   #1
Senior Member
 

Metropolitanjury's Avatar
 
Join Date: Jun 2008
Posts: 98

Default Indian Patent office to hear drug firms’ views before granting licence

The Indian patent office will provide drug innovators a chance to explain their views before a decision to grant compulsory licences against their patented medicines is taken. The patent office's decision has, for the first time, set rules for examining compulsory licence applications from local companies against multinational drug majors like Pfizer and Roche.

The patent office on July 4 dismissed a petition filed by Natco Pharma opposing the patent office's move to seek the opinion of Pfizer before granting a compulsory licence to Natco. The application seeks granting a compulsory licence to manufacture and export generic version of Pfizer's patented cancer medicine, Sunitinib, to Nepal.

The application was made under Section 92 (A) of the Patent Act and the Patent Rules, 2006, which allows the government to permit or issue compulsory licence to local manufacturers to export patent medicines to the countries, which do not have the capability to manufacture such medicines.
Since such licences are meant to be issued at the time of public health crisis, the Patent Rules do not spell out in detail the modalities of issuing them.

Natco had argued that inviting patentee (Pfizer) to appear at the hearing to contest the grant of compulsory licence was not required under the patent law.

The patent office, however, felt that the arguments of the patentee shall be helpful in deciding the terms and conditions for granting such a licence and may also be helpful in avoiding the abuse of the provisions of Section 92 (A).

"I think Natco's application itself is a weak one as they did not submit proof to suggest that there is a public health emergency in Nepal due to lack of availability of the drug. The patent controller, therefore, states in his order that one of the reasons for the ‘hearing' is to ensure that the provisions of 92 (A) are not ‘abused'. This is a sound order and helps the patent office take a better decision on a complicated area of law," Shamnad Basheer, a patent expert, said.

Natco is the first and the only Indian generic drug maker to seek the compulsory licence route to supply medicines to a least developing country.

Including the current one, Natco has two pending requests for compulsory licences to supply cancer medicines to Nepal. The other request is for permission to export Roche's cancer medicine, Erlotinib.

The patent office decision will enable Pfizer to express its views on the compulsory licence application. Natco will be given time to respond to Pfizer's submission before the patent office takes up the case for final hearing.

By Ms.Bobby Aanand, Metropolitan Jury.
Metropolitanjury is offline   Reply With Quote
Reply

Bookmark & Share



Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes Rate This Thread
Rate This Thread:

| More

Posting Rules
You may post new threads
You may post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are Off
Pingbacks are Off
Refbacks are Off

Format Your Messages
Add Forum to Google Toolbar
Forum Jump

Similar Threads

Thread Thread Starter Forum Replies Last Post
Brazil AIDS group opposes drug patent in India Metropolitanjury International Law News 1 Nov 17th, 2008 02:11 AM
Patent Office finds voice, calls for software patent sanity Metropolitanjury Law News 0 Jul 30th, 2008 06:20 AM
India rejects Boehringer's AIDS drug patent plea Metropolitanjury International Law News 0 Jun 20th, 2008 06:52 AM
A Question of Values: Drug Patent Laws Must Have Public Health Exceptions Metropolitanjury International Law Issues 0 Jun 13th, 2008 06:45 AM
Indian drug firms wary of global customs norms Metropolitanjury International Law News 0 Jun 13th, 2008 05:54 AM




All times are GMT -5. The time now is 09:14 PM.